| Jonathon Bryce-edward Olenczak, MD | |
|
1515 Holcombe Blvd, Houston, TX 77030-4009 | |
| (713) 792-6161 | |
| Not Available |
| Full Name | Jonathon Bryce-edward Olenczak |
|---|---|
| Gender | Male |
| Speciality | Plastic And Reconstructive Surgery |
| Experience | 12 Years |
| Location | 1515 Holcombe Blvd, Houston, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225395833 | NPI | - | NPPES |
| 387485102 | Other | TX | MEDICAID CSHCN |
| 387485101 | Medicaid | TX |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208200000X | Plastic Surgery | R5912 (Texas) | Secondary |
| 207YX0007X | Otolaryngology - Plastic Surgery Within The Head & Neck | R5912 (Texas) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Physicians Referral Service | 7911801410 | 2364 |
News Archive
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
The Nordic twin study investigating the heritability of subarachnoid haemorrhage (SAH) suggests that the role of genetic factors underlying the development of SAH is less than previously believed.
In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.
FEI (NASDAQ: FEIC) announced today its new Teneo VS™ scanning electron microscope (SEM), which offers a VolumeScope™ capability for life science applications. The Teneo platform tightly integrates FEI's latest-generation SEM with VolumeScope, an in-chamber microtome and proprietary analytical software to provide fully-automated, large-volume reconstructions with dramatically improved z-axis resolution.
› Verified 7 days ago
| Entity Name | Physicians Referral Service |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073574810 PECOS PAC ID: 7911801410 Enrollment ID: O20031125000953 |
News Archive
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
The Nordic twin study investigating the heritability of subarachnoid haemorrhage (SAH) suggests that the role of genetic factors underlying the development of SAH is less than previously believed.
In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.
FEI (NASDAQ: FEIC) announced today its new Teneo VS™ scanning electron microscope (SEM), which offers a VolumeScope™ capability for life science applications. The Teneo platform tightly integrates FEI's latest-generation SEM with VolumeScope, an in-chamber microtome and proprietary analytical software to provide fully-automated, large-volume reconstructions with dramatically improved z-axis resolution.
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Jonathon Bryce-edward Olenczak, MD P O Box 4439, Houston, TX 77210-4439 Ph: (713) 792-2991 | Jonathon Bryce-edward Olenczak, MD 1515 Holcombe Blvd, Houston, TX 77030-4009 Ph: (713) 792-6161 |
News Archive
A Nature Biotechnology article published online January 17 reveals that Xencor Inc.'s proprietary Fc engineering extends the half-life of antibodies while maintaining their potency and extending duration of action. These results, published in an article entitled, "Enhanced antibody half-life improves in vivo activity" demonstrate the potential of Fc engineering to impact the flexibility of route, schedule and dose for nearly any antibody.
The Nordic twin study investigating the heritability of subarachnoid haemorrhage (SAH) suggests that the role of genetic factors underlying the development of SAH is less than previously believed.
In a study published online in the Journal of Allergy and Clinical Immunology, researchers at Washington University School of Medicine in St. Louis and five other sites nationwide found that children who showed the most improvement in days without wheezing using an inhaled corticosteroid drug were caucasian boys who had allergies and had a hospitalization or emergency department visit for asthma symptoms in the year prior to the trial.
FEI (NASDAQ: FEIC) announced today its new Teneo VS™ scanning electron microscope (SEM), which offers a VolumeScope™ capability for life science applications. The Teneo platform tightly integrates FEI's latest-generation SEM with VolumeScope, an in-chamber microtome and proprietary analytical software to provide fully-automated, large-volume reconstructions with dramatically improved z-axis resolution.
› Verified 7 days ago
Ninh Ham Nguyen, D.O. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 11302 Fallbrook Dr, Ste 206, Houston, TX 77065 Phone: 832-604-3636 Fax: 281-469-8932 | |
Dr. Albert Yoon-kyu Han, M.D., PH.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 1515 Holcombe Blvd, Houston, TX 77030 Phone: 713-792-6161 | |
Hector Martinez Viera, M.D. Otolaryngology Medicare: Medicare Enrolled Practice Location: 2530 W Holcombe Blvd, Houston, TX 77030 Phone: 713-661-5255 Fax: 713-661-7683 | |
Dr. Etai Funk, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 952 Echo Ln Ste 140, Houston, TX 77024 Phone: 713-636-2757 Fax: 281-888-4083 | |
Dr. Amber Luong, M.D., PH.D Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 6431 Fannin St, Msb 5.036, Houston, TX 77030 Phone: 713-500-5421 | |
George Walter Mcreynolds, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 7789 Southwest Fwy, #470, Houston, TX 77074 Phone: 281-649-7000 Fax: 713-995-4720 | |
Dr. Anthony Brissett, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1977 Butler Blvd, E6.100, Houston, TX 77030 Phone: 713-798-3223 Fax: 713-798-2774 |